TG Therapeutics, Inc.

TGTX Healthcare
$31.41 +$0.06 (0.19%)
Market Cap: $4.59 B
Gurus Holding
6
Popularity Rank
#1346
% of Shares Held
0.70%
Net Activity (Q3 2025)
+$3.65 M

Guru Ownership Over Time

Guru Analysis for TG Therapeutics, Inc. (TGTX)

TG Therapeutics, Inc. (TGTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $32.14 M.

Top institutional holders include Steven Cohen and Ray Dalio.

Institutional sentiment is currently Bullish. This is evidenced by a $3.65 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 103.3%. Conversely, Steven Cohen reduced exposure by 49.0%.

Portfolio Manager % of portfolio Activity Shares Value Peroid
0.02% Reduce -49.0% 365,832 $13.22 M Q3 2025
0.05% New Buy 342,149 $12.36 M Q3 2025
0.99% 126,000 $4.55 M Q3 2025
0.00% New Buy 76,082 $2.75 M Q3 2025
0.00% Add 103.3% 67,811 $2.45 M Q3 2025
0.01% 45,332 $1.64 M Q3 2025

Key Holders

Top 5 by Value

$13.22 M
$12.36 M
$4.55 M
$2.45 M

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$16.35 M
Total Buy Value
New Buys: 2
Additions: 1
-$12.7 M
Total Sell Value
Reductions: 1
Sold Out: 0

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
1
Net Buyers
3

FAQs for TG Therapeutics, Inc. (TGTX)

Top Guru holders include Steven Cohen ($13.22 M), Ray Dalio ($12.36 M), John Hussman ($4.55 M). Collectively, tracked Gurus hold 1.02 M shares.

Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $3.65 M, with 3 Gurus buying and 1 Gurus selling.

In the recent quarter, 1 Gurus reduced their positions, and 0 Gurus sold out of TGTX completely. Total sell value was $12.7 M.

Yes, 2 Gurus opened new positions in TGTX, and 1 added to their existing holdings. Total buy value was $16.35 M.